Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway

MicroRNA-31 contributes to colorectal cancer development by targeting factor inhibiting HIF-1α (FIH-1)

(2014) Tao Chen et al.   CANCER BIOLOGY & THERAPY

The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme

(2014) Enfeng Wang et al.   PLoS One

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epigenetic and genetic features of 24 colon cancer cell lines

(2013) D Ahmed et al.   Oncogenesis

Targeting the Warburg Effect That Arises in Tumor Cells Expressing Membrane Type-1 Matrix Metalloproteinase

(2011) Takeharu Sakamoto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Metabolic alterations in cancer cells and therapeutic implications

(2011) Naima Hammoudi et al.   Chinese Journal of Cancer

Epigenetic changes in colorectal cancer

(2011) Yan Jia et al.   Chinese Journal of Cancer

HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer

(2010) Yanxia Wang et al.   CANCER BIOLOGY & THERAPY

miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF Pathway in Head and Neck Carcinoma

(2010) C.-J. Liu et al.   CANCER RESEARCH

Factor inhibiting HIF limits the expression of hypoxia-inducible genes in podocytes and distal tubular cells

(2010) Johannes Schödel et al.   KIDNEY INTERNATIONAL

HIF-1: upstream and downstream of cancer metabolism

(2009) Gregg L Semenza   CURRENT OPINION IN GENETICS & DEVELOPMENT

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway

(2008) Alexandra Giatromanolaki et al.   CANCER LETTERS

Biology of HIF-1α

(2008) A Weidemann et al.   CELL DEATH AND DIFFERENTIATION

Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors

(2008) A. Couvelard et al.   CLINICAL CANCER RESEARCH